- Availability of emergency contraception after its deregulation from prescription-only status: a survey of Ontario pharmacies. Dunn, Sheila; Brown, Thomas E. R.; Alldred, Jason // CMAJ: Canadian Medical Association Journal;2/12/2008, Vol. 178 Issue 4, p423
In 2005 the emergency contraception formulation of levonorgestrel (Plan B) became available in Ontario pharmacies without a prescription. We surveyed 239 pharmacies 1 month before the regulatory change and 14â€“17 months after the change to determine whether availability of the drug...
- Which drugs should be available over the counter? Fenichel, Robert R // BMJ: British Medical Journal (International Edition);7/24/2004, Vol. 329 Issue 7459, p182
Debates which pharmaceutical drugs should be available over the counter and which ones should require prescriptions. Example of levonorgestrel, a post-intercourse contraceptive; Problem of deciding which drugs should have over-the-counter status; Diagnostic considerations.
- Over-the-counter emergency contraception approved. // WHO Drug Information;1999, Vol. 13 Issue 3, p172
Reports on the approval of a emergency contraception preparation containing two tablets of levonorgestrel, Norlevo, for over-the-counter marketing in France. Efficacy of levonorgestrel.
- Levonorgestrel--Implant. // Drugs in R&D;2002, Vol. 3 Issue 6, p398
Adis Comments Levonorgestrel-releasing Norplant contraceptive implants have a recorded history of successful use by more than 200 000 women in 30 countries. The original system (Norplant-6), developed by the Population Council, comprises a set of six capsules each containing 36mg of...
- Risks and Benefits, Advantages and Disadvantages of Levonorgestrel-Releasing Contraceptive Implants. Sivin, Irving // Drug Safety;Mar2003, Vol. 26 Issue 5, p303
Levonorgestrel-releasing implants are long acting contraceptives, approved for 5 years of continuous use. Two marketed systems, the six capsule Norplant[sup Â®] and the two rod Jadelle[sup Â®], have essentially equal rates of drug release, pregnancy and adverse events over 5 years of use....
- Risks of Some Health Problems Are Elevated Among Implant Users. Rosenberg, J. // International Family Planning Perspectives;Mar2002, Vol. 28 Issue 1, p50
Reports the risks to acquire health related problems with the use of levonorgestrel-releasing implant. User of the contraceptive to develop gall bladder disease; Tendency not to be impregnated; Other mental problems to develop.
- Levonorgestrel Subdermal Implants: A Review of Contraceptive Efficacy and Acceptability. Coukell, A.J.; Balfour, J.A. // Drugs;Jun1998, Vol. 55 Issue 6, p861
Levonorgestrel 6-capsule subdermal implants (Norplant) are an effective form of reversible contraception. When implanted under the skin of the upper arm, they release drug into the circulation at a relatively constant rate over 5 years. Generally, the cumulative pregnancy rate at the end of 5...
- ellaOne is more effective at preventing pregnancies. // Practice Nurse;2/12/2010, Vol. 39 Issue 3, p8
The article focuses on a study published in "The Lancet," which found that the new emergency contraceptive pill ellaOne (ulipristal acetate) prevents more pregnancies than the widely used alternative, levonorgestrel.
- Levonorgestrel. // Reactions Weekly;3/27/2010, Issue 1294, p25
The article describes the case of a 36-year-old woman who developed a cornual pregnancy during treatment with a levonorgestrel-releasing intrauterine device (IUD) for contraception.